Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — ...
A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.
Researchers at Cellectis leveraged gene editing to create a CAR T cell that acts in an IF/THEN system. Traditional methods to develop CAR T cells that use the patient’s cells introduce challenges ...
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years ... which would greatly ...
Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
Researchers have discovered stem-like T cells, enabled by ID3 protein, that combat immune exhaustion in chronic diseases.
Researchers at the University of Pittsburgh have discovered a groundbreaking method to grow T cells in the lab that not only ...
Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...